Back to Agenda
Session 4 - Building Regulatory Agility for Improved Patient Access
Session Chair(s)
Yasha Huang
Head of Regulatory Policy Asia Pacific, Global Regulatory Policy & Intelligence
Roche Diagnostics, Singapore
Jack Wong
Founder
ARPA (Asia Regulatory Professionals Association) , Singapore
In many recent dialogues we had with policy makers and regulatory authorities regarding lesson learnt from COVID-19, the term “agility” is often heard. During the pandemic, “agility” mindset has significantly contributed to patient access for essential medical products. Regulatory agility is likely to be further explored and practiced by authorities beyond the pandemic to increase regulatory efficiency as well as improve patient access. Out of the various regulatory agility elements, we would like to focus on regulatory convergence, reliance and alternative pathways.
Speaker(s)
Outlook for Regulatory agility
Ali Al Dalaan
Saudi Food & Drug Authority, Saudi Arabia
Vice Executive President, Medical Devices Sector
Global Best Practices in Regulatory Reliance
Fatemeh Razjouyan
Regulatory Policy, Medtronic, United States
Director of Regulatory Policy -International and Harmonization, Global
Have an account?